- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02497170
Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Primary Investigator will meet with patients that attend routine visits for Diabetes 2 in the primary care office on a monthly basis to set behavior goals. Behavior goals will be set by patient's choice of 4 out of 7 of the AADE7 recommendations. The goals are health eating, being active, monitoring,taking medications, problem solving, healthy coping, and reducing risk. Once the goal is chosen, the PI and patient will make a plan to address the goals on a monthly basis for four months. There will be pre and post questionnaires that will evaluate diabetes knowledge and self-efficacy. There will also be a pre and post measure of the patient's Hemoglobin A1c which is a measurement that helps determine the extent of glycemic control over a three-month period.
The goal of the study is to determine if translation of the AADE7 behavioral goals into the primary care setting will make a difference in diabetes knowledge, self efficacy, and Hemoglobin A1c.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Somerdale, New Jersey, United States, 08083
- Melissa Souza
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients over 18 with Hemoglobin A1c 7 mmol/mol or higher will be included in the study
- Patients willing to attend minimum of 4 monthly appointments for diabetes treatment
- Patients who give written consent to participate
Exclusion Criteria:
- Patients below age 18, children are not treated in the facility for type 2 diabetes
- Patients who attend less than 4 monthly appointments for diabetes,
- Patients who do no give written consent to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Life style changes
Pre and post after education intervention Education program
|
Education of American Association of Diabetes Educations 7 behavioral goals and how to achieve them
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hemoglobin A1c
Time Frame: 4 months
|
Pre and Post Differences
|
4 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: melissa souza, Rutgers University Newark New Jersey
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO201500001877
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
University of Campania "Luigi Vanvitelli"CompletedType 2 Diabetes MellitusItaly
-
Population Health Research InstituteNovo Nordisk A/SCompletedType 2 Diabetes MellitusCanada
-
Northwell HealthPatient-Centered Outcomes Research InstituteCompletedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina
-
University of MinnesotaUniversity of Southern California; Wake Forest UniversityCompleted
-
Joslin Diabetes CenterDHR Health Institute for Research and Development; Verizon FoundationCompletedType 2 Diabetes MellitusUnited States
Clinical Trials on Education of goal setting and achievement
-
Marquette UniversityFroedtert HospitalRecruiting
-
Mount Mary UniversityCompletedBreast Cancer Female | SurvivorshipUnited States
-
National Institute of Neurological Disorders and...National Institute of Mental Health (NIMH)Completed
-
National University, SingaporeHealth Promotion Board, SingaporeCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI); MedStar Georgetown University HospitalActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Canada
-
US Department of Veterans AffairsCompleted
-
University of AlbertaAlberta Health servicesTerminatedAdolescent Obesity | Health Behavior | Primary Health Care | Life Style | Health CommunicationCanada
-
University of BirminghamEuropean Commission; Dudley NHS Foundation TrustCompletedOsteoarthritis | Physical Activity | Sedentary Lifestyle | Orthopedic Disorder | Arthropathy of Knee | Arthropathy of HipUnited Kingdom
-
Wayne State UniversityCompletedHypertension | HemodialysisUnited States
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR); Institute for Clinical Evaluative...CompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Canada